Drug
Irosustat
Irosustat: highest development phase Phase 1, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Irosustat (BN83495) NCT01840488 | Phase 1 | Breast Cancer |
Latest
No recent events.
Follow Irosustat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.